SmartSkin Adds Global Pharma Veteran Martin VanTrieste to Board of Directors
businesswire.com
news
2022-10-21 00:00:00

October 21, 2022 09:00 AM Eastern Daylight Time PALM SPRINGS, Calif.--(BUSINESS WIRE)--Onshoring pharmaceutical manufacturing has become a priority in the United States and is even backed by a $2 billion federal investment. Manufacturing capacity, according to a recent report, is readily available.



SmartSkin Technologies announced Martin VanTrieste has joined its Board of Directors to offer his unique insights on how to maximize pharmaceutical manufacturing capacity and the executive-level considerations that go into those decisions.
